12 Panel Test Cup with Adulterants
12 Panel test with adulterants offers testing for 12 different drugs including 3 adulterants.
$2.89
You save
— available on subscription
Clia Waived
As low as $1.89
| Drugs Tested |
| AMP, BAR, BUP, BZO, COC, MAMP (MET), MDMA, MTD, OPI300 (MOP), OXY, THC, PCP & 3 adulterations ADLTX (Specific Gravity, pH, and Creatinine) |
12 Panel test with adulterants offers testing for 12 different drugs including 3 adulterants.
(ADLTX) 3 adulterations Specific Gravity, pH, and Creatinine
| Drug Name | Cut-Off Level | Detection time |
| Amphetamines | 1000 ng/mL | 1-2 Days |
| Barbiturates | 300 ng/mL | 1-4 Days |
| Benzodiazepines | 300 ng/mL | 1-2 Days |
| Buprenorphine | 10 ng/mL | 2-6 Days |
| Cocaine | 300 ng/mL | 2-4 Days |
| Ecstasy | 500 ng/mL | 2-4 Days |
| Marijuana | 50 ng/mL | 5+ Days |
| Methadone | 300 ng/mL | 1-3 Days |
| Methamphetamine | 1000 ng/mL | 2-4 Days |
| Morphine | 300 ng/mL | 2-3 Days |
| Oxycodone | 100 ng/mL | 1-3 Days |
| Phencyclidine | 25 ng/mL | 7-14 Days |
| Weight | 0.08 lbs |
|---|---|
| Dimensions | 5 × 3 × 3 in |
| drug-tested |
Adulterants (ADLTX) ,Amphetamine (AMP) ,Barbiturates (BAR) ,Benzodiazepine (BZO) ,Buprenorphine (BUP) ,Cocaine (COC) ,Ecstasy (MDMA) ,Marijuana (THC) ,Methadone (MTD) ,Methamphetamine (MET) ,Opiates (OPI/MOR) ,Oxycodone (OXY) ,Phencyclidine (PCP) |
| status |
CLIA Waived ,FDA Approved |
Forensic use only
As low as $2.49
| Drugs Tested |
| AMP/1000, BUP/10, BZO/300, COC/300, ETG/500, FYL/20, MET/1000, MTD/300, OPI/300, OXY/100, PCP/25, THC/1000 |
Forensic use only
As low as $2.79
| Drugs Tested |
| ETG, AMP, BAR, BUP, BZO, COC, HCG, MAMP (MET), MDMA, MTD, OPI300 (MOP), OXY, THC, &Â FYL (Fentanyl) |
Forensic use only
As low as $2.89
| Drugs Tested |
| AMP/ 1000, OPI /300, MET/ 1000, BZO /300, COC /300, MTD/ 300, OXY /100, BUP /10, MDMA/ 500, THC/ 50, BAR /300, PCP /25, FYL/ 20, EtG/500, KRA/500, TCA/1000 |
Clia Waived
As low as $1.79
| Drugs Tested |
| AMP, BUP, BZO, COC, MAMP (MET), OPI300 (MOP), OXY & THC |
Reviews
There are no reviews yet.